企業プロフィール
Dynavax Technologies 株価・ニュース・カタリスト
上場廃止
- ティッカー:
- DVAX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for DVAX.
企業概要
事業概要
Dynavax Technologies is a vaccine company best known for HEPLISAV-B and additional innate-immune platform work. The company combines commercial product execution with immunology-driven pipeline optionality.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Dynavax sits in specialty biopharma.
ビジネスモデルの特徴
The business depends on vaccine sales, commercial traction, and the ability to expand beyond its core hepatitis-B franchise.
バイオ業界での位置付け
Dynavax is a commercial specialty-pharma name with catalyst sensitivity around vaccines, partnerships, and pipeline progress.
今後のカタリスト
- Dynavax's catalysts are HEPLISAV-B execution and CpG 1018 adjuvant partnerships, which together support the vaccine-platform story. The company improves when the commercial base and partner flow both stay healthy.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。